Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 2008

View Archived Issues

Responses to nemifitide seen in patients with severe, refractory depression

Volociximab-gemcitabine combination feasible in metastatic pancreatic cancer

Satisfactory therapeutic window of Micromet's BiTE antibody muS-110

Small molecule CCR3 antagonist shows preclinical efficacy for the treatment of asthma

New agents for treating neurological disorders described in recent patent literature

Once-daily mesalamine for active ulcerative colitis now available in Canada

New anticancer agents disclosed in recent patents

Theratechnologies reviews strategic alternatives to enhance shareholder value

Topigen initiates European phase II trial of TPI-ASM-8 in asthma patients

Lipid reports favorable results from preclinical study of delipidated autologous virus vaccine

Phase II trial demonstrates Davanat's benefits in combination with other chemotherapeutics

Ipsen withdraws application to EMEA for extension of indication for Nutropin AQ

Oasmia receives final advice from EMEA regarding phase III program for Paclical

FDA grants priority review for Millennium's Velcade for multiple myeloma

DOR BioPharma achieves 2-year stability milestone for its ricin toxin vaccine

FDA issues nonapprovable letter to Impax for Vadova for Parkinson's disease

Tigris Pharmaceuticals initiates phase I study of AFP-464 for treatment of solid tumors

Phosphagenics announces results from preclinical study of APA-01 and atorvastatin

First patients treated in Cytori's stem and regenerative cell heart attack study

Banyu obtains additional indication approval for Singulair in allergic rhinitis

Somaxon submits NDA for Silenor, a drug candidate for insomnia therapy

Novel agents for arthritic disorders disclosed in recent patents

GlaxoSmithKline obtains approval for Amerge in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...